A double-blind, controlled study of high-dose L-deprenyl in the treatment of Parkinson's disease. (Record no. 2520970)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01399 a2200397 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250512004100.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 199003s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 0362-5664 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1097/00002826-198910000-00010 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Frankel, J P |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 19900313 |
| 245 00 - TITLE STATEMENT | |
| Title | A double-blind, controlled study of high-dose L-deprenyl in the treatment of Parkinson's disease. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Clinical neuropharmacology |
| Date of publication, distribution, etc. | Oct 1989 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 448-51 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adjuvants, Pharmaceutic |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Clinical Trials as Topic |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Dose-Response Relationship, Drug |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Double-Blind Method |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Levodopa |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Parkinson Disease |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Phenethylamines |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Selegiline |
| General subdivision | administration & dosage |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kempster, P A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Stibe, C M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Eatough, V M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Nathanson, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lees, A J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Stern, G M |
| 773 0# - HOST ITEM ENTRY | |
| Title | Clinical neuropharmacology |
| Related parts | vol. 12 |
| -- | no. 5 |
| -- | p. 448-51 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1097/00002826-198910000-00010">https://doi.org/10.1097/00002826-198910000-00010</a> |
| Public note | Available from publisher's website |
No items available.